Ayala Pharmaceuticals ADXS Stock
Ayala Pharmaceuticals Price Chart
Ayala Pharmaceuticals ADXS Financial and Trading Overview
| Ayala Pharmaceuticals stock price | 0.11 USD |
| Previous Close | 1.05 USD |
| Open | 1.06 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 1.06 - 1.11 USD |
| 52 Week Range | 0.65 - 4.5 USD |
| Volume | 2.13K USD |
| Avg. Volume | 6.8K USD |
| Market Cap | 5.13M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.99 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4 USD |
ADXS Valuation Measures
| Enterprise Value | -10164623 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.4521917 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 21.550854 |
| Price/Book (mrq) | 0.52298963 |
| Enterprise Value/Revenue | -42.709 |
| Enterprise Value/EBITDA | 0.258 |
Trading Information
Ayala Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -68.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.5 USD |
| 52 Week Low | 0.65 USD |
| 50-Day Moving Average | 1.08 USD |
| 200-Day Moving Average | 1.63 USD |
ADXS Share Statistics
| Avg. Volume (3 month) | 6.8K USD |
| Avg. Daily Volume (10-Days) | 5.04K USD |
| Shares Outstanding | 4.84M |
| Float | 4.53M |
| Short Ratio | 0.95 |
| % Held by Insiders | 0.017% |
| % Held by Institutions | 16.64% |
| Shares Short | 39.89K |
| Short % of Float | 2.18% |
| Short % of Shares Outstanding | 2.18% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:80 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -16607.56% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -95.67% |
| Return on Equity (ttm) | -205.38% |
Income Statement
| Revenue (ttm) | 238K USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | -99.099% |
| Gross Profit (ttm) | N/A |
| EBITDA | -39350000 USD |
| Net Income Avi to Common (ttm) | -35421000 USD |
| Diluted EPS (ttm) | -8.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.84M USD |
| Total Cash Per Share (mrq) | 3.53 USD |
| Total Debt (mrq) | 1.66M USD |
| Total Debt/Equity (mrq) | 17.19 USD |
| Current Ratio (mrq) | 1.857 |
| Book Value Per Share (mrq) | 2.027 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -31267000 USD |
| Levered Free Cash Flow (ttm) | -16689750 USD |
Profile of Ayala Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Monmouth Junction |
| Address | 9 Deer Park Drive |
| ZIP | 08852 |
| Phone | 609 452 9813 |
| Website | https://www.ayalapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. It is also developing proprietary Lm-based antigen delivery products for patients suffering from common cancers. The company's lead candidates under development are AL102, which targets the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat various tumors, including desmoid tumors; and ADXS-504, a Lm-based therapy for early-stage prostate cancer. Ayala Pharmaceuticals, Inc. was founded in 2017 and is based in Monmouth Junction, New Jersey.
Q&A For Ayala Pharmaceuticals Stock
What is a current ADXS stock price?
Ayala Pharmaceuticals ADXS stock price today per share is 0.11 USD.
How to purchase Ayala Pharmaceuticals stock?
You can buy ADXS shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ayala Pharmaceuticals?
The stock symbol or ticker of Ayala Pharmaceuticals is ADXS.
Which industry does the Ayala Pharmaceuticals company belong to?
The Ayala Pharmaceuticals industry is Biotechnology.
How many shares does Ayala Pharmaceuticals have in circulation?
The max supply of Ayala Pharmaceuticals shares is 42.59M.
What is Ayala Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Ayala Pharmaceuticals PE Ratio is now.
What was Ayala Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Ayala Pharmaceuticals EPS is -7.99 USD over the trailing 12 months.
Which sector does the Ayala Pharmaceuticals company belong to?
The Ayala Pharmaceuticals sector is Healthcare.
Ayala Pharmaceuticals ADXS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite Total Return I XCMP | 21278.67 USD — |
+1.26
|
— — | 20945.45 USD — | 21305.05 USD — | — - | — — |
- {{ link.label }} {{link}}